Presented by The Coalition to Strengthen America’s Healthcare — Rep. Ro Khanna (D-Calif.) introduced a bill codifying ...

President Donald Trump's order to for pharmaceutical companies to cut drug prices received mixed reactions, with some members ...

For the Trump administration, pharmaceuticals are as much a national security issue as they are an issue of health or ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Importing foreign price controls via President Trump’s MFN scheme is not the answer. They risk patients access and ...

People in Tennessee, Texas and Michigan react to President Trump's executive order lowering pharmaceutical drug prices for ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

Donald Trump's recent executive orders slashing drug prices and demanding transparency in pharmacy benefit manager fees are ...

SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...

The executive order signed on May 12 has some differences from a previous executive order originally signed by the Trump administration in 2020.

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...